Semaglutide

Semaglutide is a GLP-1 Receptor Agonist supplied for laboratory research. GLP-1 receptor agonist studied in vitro for receptor binding kinetics, glucose homeostasis pathway modeling, and downstream metabolic signaling analysis.

Semaglutide is the GLP-1 receptor agonist that serves as the active compound studied in branded products such as Ozempic, Wegovy, and Rybelsus. The material offered here is unformulated semaglutide supplied strictly for in vitro research — it is not a branded, approved, or prescription medicine.

Semaglutide is supplied as a lyophilized (freeze-dried) powder — a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently — never shaken — until the powder fully dissolves. All handling is for in vitro research use only.

Store the lyophilized Semaglutide powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.

Every batch of Semaglutide is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods — high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.